⏳ Fetching live dividend data...
Home › Calculator › APDN Dividend Calculator 2026
Applied DNA Sciences, Inc. · NASDAQ
Price: $5.62 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in APDN → $88195835.64M in 10 years · $7,329,539,682,522.40/month
Applied DNA Sciences, Inc. specializes in devising and marketing sophisticated DNA-centric technological solutions across diverse sectors. Its activities encompass nucleic acid-based in vitro diagnostics and the preclinical development and production of nucleic acid-based pharmaceuticals. Furthermore, the company offers robust solutions for bolstering supply chain security, combating counterfeiting, and preventing theft. Key offerings for product authenticity and supply chain integrity include SigNature molecular tags, which imbue products with forensic traceability and protection, thereby strengthening brand defense and supply chain resilience while aiding in criminal identification and prosecution. To facilitate real-time, field-based verification of these tags, they provide SigNify IF portable DNA readers along with corresponding SigNify consumable reagent test kits. The CertainT platform represents a holistic approach, integrating tagging, testing, and tracking capabilities, empowering manufacturers, brands, and trade organizations to substantiate their product claims with verifiable evidence. Within the diagnostic realm, the company produces the LineaTM COVID-19 Assay Kit, a PCR-based molecular diagnostic test. It also offers the safeCircle COVID-19 diagnostic kit, specifically designed to help curtail viral transmission within communal settings such as schools or workplaces. Additionally, Applied DNA Sciences delivers contract research and manufacturing services for the burgeoning nucleic acid-based therapeutic markets during their preclinical phases. This extends to providing contract research for clients involved in preclinical studies of RNA-based drugs and biologics. The company is also at the forefront of developing an innovative technology for the capture and identification of invasive circulating tumor cells, utilizing a proprietary functional assay to isolate live invasive tumor cells and their associated lymphocytes. Operating internationally, the firm maintains a significant footprint across the United States, Europe, and Asia. Founded in 1983, the organization was initially known as Datalink Systems, Inc., before officially changing its name to Applied DNA Sciences, Inc. in 2002. Its corporate headquarters are located in Stony Brook, New York.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open APDN position with:
Real after-tax yield depends on where you live and how you hold APDN.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 35.59% | 32.79% | $3,559 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 30.25% | 27.45% | $3,025 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 28.47% | 25.67% | $2,847 / yr |
| 🇬🇧 UK ISA | 0% | 35.59% | 32.79% | $3,559 / yr |
| 🇬🇧 UK Taxable | 8.75% | 32.48% | 29.68% | $3,248 / yr |
| 🇨🇦 TFSA | 0% | 35.59% | 32.79% | $3,559 / yr |
| 🇨🇦 CA Taxable | 25% | 26.69% | 23.89% | $2,669 / yr |
| 🇦🇺 Super (pension) | 15% | 30.25% | 27.45% | $3,025 / yr |
| 🇦🇺 AU Taxable | 30% | 24.91% | 22.11% | $2,491 / yr |
| 🇩🇪 DE Taxable | 26.375% | 26.20% | 23.40% | $2,620 / yr |
| 🇫🇷 FR Taxable | 30% | 24.91% | 22.11% | $2,491 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
APDN pays quarterly — 4 times per year. Next ex-div: TBD.
How APDN compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for APDN sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2023-03-23 | 98,039 | $1.08 | $105.9K | ||
| A-Award | 2023-03-23 | 91,667 | — | — | ||
| A-Award | 2023-03-23 | 1,961 | $1.08 | $2.1K | ||
| A-Award | 2023-03-23 | 98,039 | $1.08 | $105.9K | ||
| A-Award | 2023-03-23 | 91,667 | — | — | ||
| A-Award | 2023-03-23 | 1,961 | $1.08 | $2.1K | ||
| A-Award | 2023-03-23 | 99,306 | — | — | ||
| A-Award | 2023-03-23 | 98,039 | $1.08 | $105.9K | ||
| A-Award | 2023-03-23 | 10,294 | $1.08 | $11.1K | ||
| A-Award | 2023-01-25 | 75,099 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the APDN dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Applied DNA Sciences, Inc. (APDN) is currently trading at $5.62, 100% below its 52-week high. The current dividend yield is 35.59% based on an annual payout of $2.00 per share.
Applied DNA Sciences, Inc. (APDN) is a healthcare stock currently trading at $5.62 with a dividend yield of 35.59%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →